Swiss fine chemicals firm Lonza has secured two new contracts for its contract manufacturing division for monoclonal antibodies to treat …
Our round-up of developments in the contract research sector includes updates from Kendle, Bilcare, Quintiles, Melbourn Scientific, Lonza, and Medidata …
Swiss chemical manufacturer Lonza will close three of its plants in Europe and the US by the end of the …
Pharmafocus’ round-up of developments in the pharmaceutical manufacturing sector includes new contracts for CMOs Lonza and DSM, facility news for …
Swiss contract manufacturer Lonza will manufacture a newly-approved treatment for chronic lymphocytic leukaemia after signing a deal with Genmab and …
Lonza said it has elected not to proceed with a $460 million bid to buy Canadian contract manufacturing and development …
Swiss contract manufacturer Lonza has broken ground a new manufacturing unit for cell-based therapies, located at the Tuas Biomedical Park …
Swiss chemical and contract manufacturing group Lonza saw a slump in sales and profits in the first half of the …
Altus Therapeutics has officially called a halt to a supply agreement with contract manufacturer Lonza in the latest round of …
Pharmafocus presents a round-up of developments in the pharmaceutical manufacturing sector, including new facility updates from Alcon, Lonza, Cell Therapeutics, …
The European Commission has given a green light to the formation of a joint venture company between Teva and Lonza …